Skip to main content

Sectors

We Serve

Our Sectors


Theravest works with organizations across the healthcare and life sciences ecosystem, from emerging biopharma companies and growing pharmaceutical businesses to established life sciences organizations and investment partners. Our support is tailored to each client’s stage, priorities, and development challenges, combining scientific, regulatory, strategic, and commercial expertise to help teams move forward with greater clarity and confidence.

Biotech & Life sciences

Connecting scientific innovation with practical development strategy.

We work with biotechnology and life sciences organizations to translate promising science into structured development programs, combining technical insight with strategic direction to support regulatory alignment, execution, and long-term value creation.

Scientific Strategy
Translational Planning
Regulatory Pathways

Biopharma Startups

Turning early scientific potential into a focused development path.

We support emerging biopharma companies with strategic, scientific, and regulatory guidance designed to reduce uncertainty, prioritize resources, and establish a clear path from early development toward meaningful value inflection points.

Development Strategy
Regulatory Planning
CMC & Formulation Strategy

Midsize Pharma

Strengthening development programs and evolving portfolios.

Theravest helps growing and established pharmaceutical companies address complex development challenges, optimize existing programs, and identify opportunities across their portfolios through integrated scientific, regulatory, strategic, and commercial expertise.

Portfolio Strategy
Development Program Support
Commercial Readiness

Investors & Venture Capital

Scientific and strategic insight for better-informed investment decisions.

We support investors and venture capital firms with independent scientific and strategic assessment, helping evaluate opportunities, identify development risks, understand competitive positioning, and make more informed investment decisions.

Technical Due Diligence
Development Risk Assessment
Portfolio Assessment